The emerging microbiome‐based approaches to <scp>IBD</scp> therapy: From <scp>SCFAs</scp> to urolithin A-Reference-Cited by-同舟云学术

The emerging microbiome‐based approaches to IBD therapy: From SCFAs to urolithin A

Published:2022-08 Issue:8-9 Volume:23 Page:412-434
ISSN:1751-2972
Container-title:Journal of Digestive Diseases
language:en
Short-container-title:J of Digest Diseases

Author:

Rudiansyah Mohammad¹,Abdalkareem Jasim Saade²,S. Azizov Bakhadir³,Samusenkov Vadim⁴,Kamal Abdelbasset Walid⁵,Yasin Ghulam⁶,Mohammad Hawraa Jabbar⁷,Jawad Mohammed Abed⁸,Mahmudiono Trias⁹,Hosseini‐Fard Seyed Reza¹⁰,Mirzaei Rasoul¹¹^ORCID,Karampoor Sajad¹²

Affiliation:

1. Division of Nephrology & Hypertension, Department of Internal Medicine Faculty of Medicine, Universitas Lambung Mangkurat, Ulin Hospital Banjarmasin Indonesia

2. Al‐Maarif University College Medical Laboratory Techniques Department Al‐Anbar‐Ramadi Ramadi Iraq

3. Department of Therapeutic Disciplines No.1 Tashkent State Dental Institute Tashkent Uzbekistan

4. Sechenov First Moscow State Medical University Moscow Russia

5. Department of Health and Rehabilitation Sciences, College of Applied Medical Sciences Prince Sattam bin Abdulaziz University Al Kharj Saudi Arabia

6. Department of Botany University of Bahauddin Zakariya University Multan Pakistan

7. Al‐Manara College For Medical Sciences Maysan Iraq

8. Al‐Nisour University College Baghdad Iraq

9. Department of Nutrition Faculty of Public Health Universitas Airlangga Indonesia

10. Department of Biochemistry, School of Medicine Tehran University of Medical Sciences Tehran Iran

11. Venom and Biotherapeutics Molecules Lab, Medical Biotechnology Department, Biotechnology Research Center Pasteur Institute of Iran Tehran Iran

12. Gastrointestinal and Liver Diseases Research Center Iran University of Medical Sciences Tehran Iran

Publisher

Wiley

Subject

Gastroenterology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1751-2980.13131

Reference270 articles.

1. Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD

2. Immunopathogenesis of IBD: current state of the art

3. JAK–STAT pathway targeting for the treatment of inflammatory bowel disease

4. Clinical Pharmacology of Janus Kinase Inhibitors in Inflammatory Bowel Disease

5. New mediators of immunity and inflammation in inflammatory bowel disease

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Family of Cyclic Lipopeptides Found in Human Isolates of Bacillus Ameliorates Acute Colitis via Direct Agonism of Toll-Like Receptor 2 in a Murine Model of Inflammatory Bowel Disease;Digestive Diseases and Sciences;2024-08-07

2. Pre- to Postbiotics: The Beneficial Roles of Pediatric Dysbiosis Associated with Inflammatory Bowel Diseases;Microorganisms;2024-08-02

3. Elephantopus scaber L. Polysaccharides Alleviate Heat Stress-Induced Systemic Inflammation in Mice via Modulation of Characteristic Gut Microbiota and Metabolites;Nutrients;2024-01-16

4. Microbiome-Based Therapeutics in Immunological Disorders;Human Microbiome;2024

5. Pomegranate (Punica granatum L.) and Its Rich Ellagitannins as Potential Inhibitors in Ulcerative Colitis;International Journal of Molecular Sciences;2023-12-16